Using convalescent plasma transfusion as adjunctive therapy may not help prevent disease progression among hospitalized coronavirus disease (COVID-19) patients, the Department of Science and Technology (DOST) said Thursday, Dec. 9. (Photo by Rodrigo ARANGUA / AFP / MANILA BULLETIN) Results of the...
The Department of Science and Technology (DOST) disclosed on Friday, July 23, the completion of the country’s clinical trial on the efficacy and safety of convalescent plasma transfusion as adjunctive therapy to prevent disease progression among hospitalized coronavirus disease (COVID-19)...
US health experts said Tuesday they are halting clinical trials of convalescent blood plasma in patients with mild to moderate Covid symptoms after preliminary results showed no benefit from the treatment. (Photo by Rodrigo ARANGUA / AFP / MANILA BULLETIN) The trial that began in August involved...